Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

OBJECTIVE: Anti-HBe seroconversion and HBsAg loss are important therapeutic endpoints in patients with hepatitis B virus (HBV) infection. Quantitative measures of hepatitis B surface antigen (qHBsAg) and e antigen (qHBeAg) have been identified as potentially useful indicators of therapeutic response...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Matthews, Gail V., Ali, Rachel J., Avihingsanon, Anchalee, Amin, Janaki, Hammond, Rachel, Bowden, Scott, Lewin, Sharon R., Sasadeusz, Joe, Littlejohn, Margaret, Locarnini, Stephen L., Ruxrungtham, Kiat, Dore, Gregory J.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622017/
https://ncbi.nlm.nih.gov/pubmed/23593455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061297
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares